Biochimistes et Biophysiciens
Sciences de la Vie, Physiques et SocialesExposition à l'IA
- Source des données: BLSPublié: 2026-08
Très élevée· relative
FaibleQuatre bandes relativesTrès élevéeValeur par groupe professionnel
Échelle, base et source
Quatre bandes relatives (Faible / Modérée / Élevée / Très élevée)
831 métiers détaillés du tableau des projections d'emploi du BLS. La valeur est attribuée par code de la National Employment Matrix (NEM), si bien que les métiers partageant un code NEM reçoivent la même bande
- Source des données: AnthropicPublié: 2026-03
0.076
0.000Étendue des valeurs présentées ici0.745Échelle, base et source
- Source des données: ILOPublié: 2025
0.40
0.09Étendue des valeurs présentées ici0.70Valeur par groupe professionnel
Échelle, base et source
Indice d'exposition à l'IA générative, 0–1 tel que publié
Groupe de base CITP-08 — tous les métiers partageant le code reçoivent cette valeur
Calculé par ce site, non publié par l'OIT : sur les 1 012 professions que ce site relie au jeu de données de l'OIT, 39% atteignent ou dépassent cette valeur.
Quelle est la nature de la valeur publiée par cette source
La catégorie BLS est un rang relatif et non un niveau absolu, et ce n'est pas une mesure de première main : elle regroupe en quatre bandes les rangs centiles du métier dans plusieurs études publiées. Ce n'est ni une prévision d'emploi ou de salaire, ni une probabilité d'adoption, et elle ne distingue pas automatisation et augmentation.
Task-level exposure
| Task | Claude.aiRaw / share % | APIRaw / share % |
|---|---|---|
Prepare reports or recommendations, based upon research outcomes.19-1021 | 0.00000.0 | 0.00000.0 |
Study the chemistry of living processes, such as cell development, breathing and digestion, or living energy changes, such as growth, aging, or death.19-1021 | 0.00000.0 | —0 |
Write grant proposals to obtain funding for research.19-1021 | 0.00000.0 | —0 |
| Not observed on any surface — 21 task(s) — These tasks have no row in the source for this release. The 0 in the share row is a display-stage composition ratio; absence is what the — in the raw row states. | ||
Develop new methods to study the mechanisms of biological processes. | —0 | —0 |
Manage laboratory teams or monitor the quality of a team's work. | —0 | —0 |
Share research findings by writing scientific articles or by making presentations at scientific conferences. | —0 | —0 |
Develop or execute tests to detect diseases, genetic disorders, or other abnormalities. | —0 | —0 |
Develop or test new drugs or medications intended for commercial distribution. | —0 | —0 |
Study the mutations in organisms that lead to cancer or other diseases. | —0 | —0 |
Study spatial configurations of submicroscopic molecules, such as proteins, using x-rays or electron microscopes. | —0 | —0 |
Determine the three-dimensional structure of biological macromolecules. | —0 | —0 |
Research the chemical effects of substances, such as drugs, serums, hormones, or food, on tissues or vital processes. | —0 | —0 |
Research how characteristics of plants or animals are carried through successive generations. | —0 | —0 |
Study physical principles of living cells or organisms and their electrical or mechanical energy, applying methods and knowledge of mathematics, physics, chemistry, or biology. | —0 | —0 |
Isolate, analyze, or synthesize vitamins, hormones, allergens, minerals, or enzymes and determine their effects on body functions. | —0 | —0 |
Design or perform experiments with equipment, such as lasers, accelerators, or mass spectrometers. | —0 | —0 |
Teach or advise undergraduate or graduate students or supervise their research. | —0 | —0 |
Research transformations of substances in cells, using atomic isotopes. | —0 | —0 |
Examine the molecular or chemical aspects of immune system functioning. | —0 | —0 |
Design or build laboratory equipment needed for special research projects. | —0 | —0 |
Prepare pharmaceutical compounds for commercial distribution. | —0 | —0 |
Develop methods to process, store, or use foods, drugs, or chemical compounds. | —0 | —0 |
Investigate the nature, composition, or expression of genes or research how genetic engineering can impact these processes. | —0 | —0 |
Produce pharmaceutically or industrially useful proteins, using recombinant DNA technology. | —0 | —0 |
Values in this tab are predicted labels, not observations. Eloundou et al. (2023) published two rating regimes — human raters and GPT-4 — and the β shown here is derived from the GPT-4 rater basis alone; the same task can take a different value under the other regime. The unit and the meaning differ from the observed shares (%) in the other tabs, so do not place them on the same axis.
| Task | βE1 + 0.5 × E2 |
|---|---|
Prepare reports or recommendations, based upon research outcomes.O*NET Task ID 12929 | 1.0 |
Share research findings by writing scientific articles or by making presentations at scientific conferences.O*NET Task ID 12932 | 1.0 |
Write grant proposals to obtain funding for research.O*NET Task ID 21168 | 1.0 |
Develop new methods to study the mechanisms of biological processes.O*NET Task ID 12930 | 0.5 |
Manage laboratory teams or monitor the quality of a team's work.O*NET Task ID 12931 | 0.5 |
Develop or execute tests to detect diseases, genetic disorders, or other abnormalities.O*NET Task ID 12933 | 0.5 |
Develop or test new drugs or medications intended for commercial distribution.O*NET Task ID 12934 | 0.5 |
Study the mutations in organisms that lead to cancer or other diseases.O*NET Task ID 12935 | 0.5 |
Study spatial configurations of submicroscopic molecules, such as proteins, using x-rays or electron microscopes.O*NET Task ID 12936 | 0.5 |
Study the chemistry of living processes, such as cell development, breathing and digestion, or living energy changes, such as growth, aging, or death.O*NET Task ID 12937 | 0.5 |
β = E1 + 0.5 × E2 · E1 = tasks where direct LLM access alone cuts time by at least 50%, E2 = tasks where software built on top of an LLM cuts time by at least 50%. Values take only 0 / 0.5 / 1.0.
Data sources & licenses — O*NET®, Anthropic Economic Index, Eloundou et al. (2023): see full notices on the Credits page